Thomas DiVittorio

This profile gathers the share dealings of Thomas DiVittorio across 2 companies, led by Genesis Healthcare, Inc. and Genesis Healthcare Corp. We count 27 filings; the first trade dates from 1 January 2006 and the latest from 15 May 2021.

In open-market terms, that means 1 purchase worth €81k on one side and 10 sales worth €96k on the other. On balance, insiders were net sellers of €15k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 8 share grants.

On 28 May 2021 came the latest disclosure, a share grant for €12k in Genesis Healthcare, Inc. The clock since the last published purchase (13 November 2015) now reads 3,998 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.